Related Experiment Video
Updated: Dec 26, 2025

Practical Use of RNA Interference: Oral Delivery of Double-stranded RNA in Liposome Carriers for Cockroaches
Published on: May 1, 2018
Developments in siRNA Modification and Ligand Conjugated Delivery To Enhance RNA Interference Ability
Ander Maguregui1, Hiroshi Abe2
1Bioorganic Chemistry Laboratory, Graduate School of Science, Nagoya University, Chikusa-ku, Nagoya, Aichi, 464-0813, Japan.
Small interfering RNA (siRNA) holds promise for treating diseases by reducing harmful protein production. Chemical modifications and ligand conjugations are key strategies to improve siRNA delivery and cell uptake for therapeutic applications.
Area of Science:
- Biotechnology
- Molecular Biology
- Therapeutics
Background:
- RNA interference (RNAi) using small interfering RNA (siRNA) offers potential for disease treatment by inhibiting damaging protein translation.
- Significant challenges exist in the therapeutic application of siRNA, primarily concerning efficient delivery and cellular uptake.
- Overcoming these delivery hurdles is crucial for realizing the full therapeutic potential of siRNA.
Purpose of the Study:
- To review common chemical modifications of siRNA duplexes.
- To discuss ligand conjugates as a promising strategy for targeted siRNA delivery.
- To highlight advancements in overcoming siRNA delivery and cell uptake challenges.
Main Methods:
- Review of existing literature on siRNA chemical modifications.
- Analysis of studies involving ligand conjugation to siRNA.
- Evaluation of the impact of modifications and conjugations on siRNA pharmacokinetics, stability, efficacy, and targeting.
Main Results:
- Chemical modifications enhance siRNA stability, pharmacokinetics, and efficacy.
- Ligand conjugation improves membrane penetration, targetability, and potency of siRNA.
- Specific modifications and ligand conjugates show significant promise for targeted delivery.
Conclusions:
- Chemical modifications and ligand conjugations are vital for effective siRNA therapeutics.
- Targeted delivery strategies are advancing the clinical application of siRNA.
- Continued research in siRNA modification and conjugation will drive therapeutic innovation.
More Related Videos
09:09Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
Published on: May 2, 2019
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Small interfering RNAs (siRNA)
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Types of RNA
RNA Performs Diverse...